Capsules Tablets

For hyperprolactinemic conditions.

Adults, initial: 0.5-2.5 mg/day with meals; then, increase dose by 2.5 mg q 3-7 days until optimum response observed (usual: 5-7.5 mg/day; range: 2.5-15 mg/day). For amenorrhea/galactorrhea, do not use for more than 6 months. Side effects may be reduced by temporarily decreasing the dose to 1/2 tablet 2-3 times/day.

Parkinsonism. Initial: 1.25 mg (V2 tablet) b.i.d. with meals while maintaining dose of lev-odopa, if possible. Dosage may be increased q 14-28 days by 2.5 mg/day with meals. The usual dosage range is 10-40 mg/day. Any decrease in

B dosage should be done gradually in 2.5-mg decrements.

Acromegaly. Initial: 1.25-2.5 mg for 3 days with food and on retiring; then, increased by 1.25-2.5 mg q 3-7 days until optimum response observed. Usual optimum therapeutic range: 20-30 mg/day, not to exceed 100 mg/day. Clients should be reevaluat-ed monthly and dosage adjusted accordingly.

Hyperprolactinemia associated with pituitary adenomas. Maintenance: 0.625-10 mg/day for 6 to 52 months.

0 0

Post a comment